Kenyon Farrow is the senior editor with TheBody.com and TheBodyPro.com. Kenyon has a long track record working in communities impacted by HIV as an activist, writer, and strategist. Prior to joining TheBody.com, he served as U.S. & Global Health Policy director for Treatment Action Group (TAG), where he led a research project to explore the role of community mobilization in the U.S. HIV response and helped develop strategies for southern jurisdiction's ending-the-epidemic campaigns. Kenyon has also worked on campaigns large and small, local, national, and global on issues related to criminalization/mass imprisonment, homelessness, and LGBT rights.
In addition to his political work, Kenyon is a prolific essayist and author. He is the co-editor of the book Letters From Young Activists: Today's Rebels Speak Out. His work has also appeared in many anthologies including Spirited: Affirming the Soul of Black Lesbian and Gay Identity, For Colored Boys Who Have Considered Suicide When The Rainbow Is Still Not Enough, We Have Not Been Moved: Resisting Racism and Militarism in 21st Century America, and Black Gay Genius: Answering Joseph Beam's Call. His work has also appeared on websites and in publications such as The Body.com, POZ, The Atlantic, TheGrio, Colorlines, ReWire News, The American Prospect, and AlterNet.
Kenyon's work has been recognized by many institutions including Out Magazine's "Out 100" and The Advocate magazine's "40 Under 40." He was also named a "Modern Black History Hero" by Black Entertainment Television.
Follow Kenyon on Twitter: @kenyonfarrow.
Within the past year, Kenyon Farrow has had some form of official relationship with each of the following groups/organizations that have a stake in the fight against HIV. These disclosures were last updated on November 1, 2017.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|Sex and the HIV Reservoir: New Research Points to the Powerful Effect of Estrogen|
|First U.S. Failure of Truvada as PrEP Is Reported at IDWeek|
|Post-AIDS 2018 Updates on HIV Cure Research|
|On-Demand PrEP Is Great. Now, What About Women?|
|High Rates of Anal HPV Infection in Gay Men Using PrEP in IPERGAY: The Role of Vaccination|